A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults

Clinical trial NCT05011526 · COMPLETED

Trial details

NCT number: NCT05011526
Sponsor: Medigen Vaccine Biologics Corp.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Covid19 Vaccine

Start date: 2021-10-08
Primary completion: 2021-12-28
Enrollment: 1030

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.